Table 3.
Study variables in patients with 3-month favorable outcome and bad prognosis
| Variable |
Favorable outcome (n = 58)
|
Bad prognosis (n = 66)
|
P |
|---|---|---|---|
| n (%) | n (%) | ||
| Sex (Men) | 38 (65.5) | 35 (59.1) | 0.46 |
| Hypertension | 31 (53.4) | 45 (68.2) | 0.09 |
| Diabetes mellitus | 11 (19.0) | 16 (24.2) | 0.48 |
| Smoking (current) | 12 (20.7) | 13 (19.7) | 0.89 |
| Hypertriglyceridemia | 8 (13.8) | 6 (9.1) | 0.41 |
| Previous ischemic heart disease | 12 (20.7) | 11 (16.7) | 0.57 |
| Previous CABG | 2 (3.4) | 5 (7.6) | 0.45 |
| Previous AF | 7 (12.1) | 20 (30.3) | 0.01* |
| Previous stroke | 7 (12.1) | 7 (10.6) | 0.80 |
| Previous congestive heart disease | 3 (5.7) | 6 (12.0) | 0.31 |
| Antiplatelet drug | 11 (23.9) | 18 (36.7) | 0.18 |
| 24-hour ICH | 2 (3.4) | 11 (6.7) | 0.02* |
| Variable | Median (IQR) | Median (IQR) | P |
| Age (year) | 60 (52-69) | 70 (59-75) | < 0.01* |
| Systolic blood pressure (mmHg) | 142 (128-160) | 140 (122-150) | 0.19 |
| Diastolic blood pressure (mmHg) | 85 (80-96) | 80 (79-90) | 0.22 |
| Serum hemoglobin (mg/dl) | 14.0 (13.0-14.6) | 13.6 (12.3-15.2) | 0.85 |
| Platelet (× 1000/ml) | 208 (182-248) | 212 (163-266) | 0.62 |
| INR (U) | 1.00 (1.00-1.07) | 1.00 (1.00-1.10) | 0.15 |
| Serum glucose (mg/dl) | 128 (105-149) | 140 (115-194) | 0.09 |
| GFR (ml/minute/1.73 m2) | 68 (55-87) | 60 (45-76) | 0.02* |
| Symptom-to-treatment (minute) | 128 (105-170) | 147 (130-165) | 0.11 |
| Baseline NIHSS | 10 (7-14) | 17 (13-19) | < 0.01* |
CABG: Coronary artery bypass grafting; ICH: Intracranial hemorrhage; INR: international normalized ratio; GFR: Glomerular filtration rate; NIHSS: The National Institutes of Health Stroke Scale; AF: Atrial fibrillation
*
P value of less than 0.05 which is statistically significant.